Black Rock Inc. Allakos Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Allakos Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,267,129 shares of ALLK stock, worth $418,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,267,129
              Previous 4,720,771
              
        
           73.16%
        
      
          
        Holding current value
$418,152
            Previous $5.95 Million
            
        
           78.7%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  13 transactions
	
  Others Institutions Holding ALLK
# of Institutions
3Shares Held
1.29MCall Options Held
0Put Options Held
0About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $28M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...